BIFIDO Co. Ltd (238200) - Total Liabilities
Based on the latest financial reports, BIFIDO Co. Ltd (238200) has total liabilities worth ₩12.57 Billion KRW (≈ $8.52 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See defensive interval ratio of BIFIDO Co. Ltd to measure how many days the company can operate on defensive assets alone.
BIFIDO Co. Ltd - Total Liabilities Trend (2016–2025)
This chart illustrates how BIFIDO Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check BIFIDO Co. Ltd (238200) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
BIFIDO Co. Ltd Competitors by Total Liabilities
The table below lists competitors of BIFIDO Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SPECO Ltd
KQ:013810
|
Korea | ₩19.54 Billion |
|
CTRL Group Limited Ordinary Shares
NASDAQ:MCTR
|
USA | $11.92 Million |
|
Prajay Engineers Syndicate Limited
NSE:PRAENG
|
India | Rs3.29 Billion |
|
Yulho Co. Ltd
KQ:072770
|
Korea | ₩96.88 Billion |
|
Batavia Prosperindo Trans Tbk PT
JK:BPTR
|
Indonesia | Rp1.52 Trillion |
|
COCRYSTAL PHARMA NEW O.N.
F:8CC
|
Germany | €3.38 Million |
|
COSMOS HEALTH NEW DL-01
F:V67A
|
Germany | €47.05 Million |
|
Capital Point
TA:CPTP
|
Israel | ILA26.64 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down BIFIDO Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see BIFIDO Co. Ltd assets under control.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BIFIDO Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BIFIDO Co. Ltd (2016–2025)
The table below shows the annual total liabilities of BIFIDO Co. Ltd from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩15.37 Billion ≈ $10.42 Million |
+5.82% |
| 2024-12-31 | ₩14.53 Billion ≈ $9.84 Million |
-27.49% |
| 2023-12-31 | ₩20.03 Billion ≈ $13.58 Million |
+718.48% |
| 2022-12-31 | ₩2.45 Billion ≈ $1.66 Million |
-38.89% |
| 2021-12-31 | ₩4.01 Billion ≈ $2.71 Million |
-40.25% |
| 2020-12-31 | ₩6.70 Billion ≈ $4.54 Million |
+243.69% |
| 2019-12-31 | ₩1.95 Billion ≈ $1.32 Million |
-3.14% |
| 2018-12-31 | ₩2.01 Billion ≈ $1.36 Million |
-89.03% |
| 2017-12-31 | ₩18.35 Billion ≈ $12.44 Million |
+0.47% |
| 2016-12-31 | ₩18.27 Billion ≈ $12.38 Million |
-- |
About BIFIDO Co. Ltd
BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.